STOCK TITAN

CEO of Scientific Industries (SCND) awarded 130,000 stock options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Scientific Industries Inc. reported that President and CEO Helena R. Santos received a grant of stock options covering 130,000 shares of common stock on February 17, 2026. The options have an exercise price of $0.60 per share, were granted at no purchase cost, and vest on a 4 year cliff from the grant date. Following this award, Santos holds options on a total of 563,388 shares directly. This is a compensation-related grant rather than an open-market share purchase or sale.

Positive

  • None.

Negative

  • None.
Insider SANTOS HELENA R
Role President and CEO
Type Security Shares Price Value
Grant/Award Stock Option 130,000 $0.00 --
Holdings After Transaction: Stock Option — 563,388 shares (Direct)
Footnotes (1)
  1. [object Object]
Option grant size 130,000 options Stock option grant on February 17, 2026
Exercise price $0.60 per share Conversion or exercise price of granted options
Total options held 563,388 options Total derivative shares following transaction
Grant cost $0.00 per option Transaction price per option at grant
Option expiration February 17, 2036 Expiration date of granted stock options
Vesting schedule 4 year cliff Vesting based on four-year cliff from grant date
Stock Option financial
"security_title: "Stock Option" with underlying common stock"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
conversion or exercise price financial
"conversion_or_exercise_price: "0.6000" per share"
4 year cliff financial
"Vesting is based on 4 year cliff from date of option grant."
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
derivative transaction financial
"derivativeTransactionCount: 1 in transactionSummary"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
SANTOS HELENA R

(Last)(First)(Middle)

(Street)

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
SCIENTIFIC INDUSTRIES INC [ SCND ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
President and CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option$0.602/17/202602/17/2026A130,000 (1)02/17/2036Common Stock130,000$0563,388D
Explanation of Responses:
1. Vesting is based on 4 year cliff from date of option grant.
Helena Santos04/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did SCIENTIFIC INDUSTRIES INC (SCND) report for Helena R. Santos?

Helena R. Santos, President and CEO of Scientific Industries Inc. (SCND), received a grant of stock options for 130,000 shares. The award is a compensation grant, not an open-market trade, and gives rights to buy common stock at a set exercise price.

What are the key terms of Helena R. Santos’s new SCND stock options?

The new stock options cover 130,000 shares of Scientific Industries common stock at an exercise price of $0.60 per share. They were granted at no purchase cost and vest on a four-year cliff schedule starting from the February 17, 2026 grant date.

How many Scientific Industries (SCND) option shares does Helena R. Santos hold after this grant?

After the February 17, 2026 grant, Helena R. Santos holds stock options over 563,388 shares. This total includes the newly granted 130,000 options and represents her direct derivative holdings as reported in the Form 4 insider filing.

Is Helena R. Santos’s SCND Form 4 transaction a stock purchase or sale?

The Form 4 shows a grant of stock options, not a market purchase or sale. Santos acquired the options as compensation with an exercise price of $0.60 per share, meaning no immediate cash transaction in the open market occurred.

When do Helena R. Santos’s new Scientific Industries options vest?

The footnote states that vesting is based on a four-year cliff from the option grant date. That means none of the 130,000 options vest before the four-year mark from February 17, 2026, after which the entire grant becomes exercisable at once.